Tag Archive for Q1 2025

Primerica Reports 9% Increase in Revenues, Strong First Quarter 2025

Primerica, Inc. (NYSE: PRI), a leading provider of financial services to middle-income families in North America, has announced financial results for the first quarter ended March 31, 2025.
Total revenues reached $804.8 million, a 9% increase compared to the first quarter of 2024. Net income was $169.1 million, up 14% year-over-year. Earnings per diluted share were $5.05, an increase of 19% compared to the prior year period.
Adjusted results were similarly strong:

Adjusted operating revenues: $803.6 million, up 9%

Adjusted net operating income: $168.1 million, up 14%

Diluted adjusted operating EPS: $5.02, up 20%

Glenn Williams, CEO of Primerica said.

“Our results this quarter highlight the strength and consistency of our business, Momentum in our Investment and Savings Products Segment, along with steady performance in our Term Life business, contributed to strong financial results this quarter.”

Segment Highlights
Term Life Insurance

Revenue: $457.8 million (↑ 4%)

Policies Issued: 86,415

Productivity: 0.19 policies/month per life-licensed rep

Operating margin: 22.1%

Investment and Savings Products (ISP)

Product Sales: $3.6 billion (↑ 28%)

Net Inflows: $839 million

Client Asset Value: $110 billion (↑ 6%)

Segment Revenues: $290.8 million (↑ 19%)

Pre-tax income: $81.3 million (↑ 24%)

Corporate and Other Distributed Products

Adjusted operating loss: $8.0 million (vs. $11.7M loss in Q1 2024)

Distribution Growth

New Recruits: 100,867

Newly Licensed Representatives: 12,339

Total Life-Licensed Sales Force: 152,167 (↑ 7% YoY)

Capital

Read more...

Medifast Reports Q1 2025 Financial Results

Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, reported results for the first quarter ended March 31, 2025.
First Quarter 2025

Revenue of $115.7 million, with revenue per active earning coach of $4,556
Independent active earning OPTAVIA coaches of 25,400
Net loss of $0.8 million, which includes an unrealized gain on investment in LifeMD (Nasdaq: LFMD) common stock of $0.4 million (net of tax)
Loss per share of $0.07
Cash, Cash Equivalents, and Investment Securities of $164.6 million with no debt

“In today’s health and wellness landscape, more people than ever are seeking guidance not just for weight loss but for learning how to lead a healthier lifestyle,”

said Dan Chard, CEO of Medifast.

“However, research we commissioned indicates that 83% of those looking to lose weight lack confidence in their ability to transition to a healthy lifestyle for long-term health and wellness improvements.”

Chard continued,

“Our OPTAVIA program is designed to provide this essential knowledge through personalized support and clinically studied, tailored plans. The journey begins with our OPTAVIA coaches, who guide and help our customers in achieving and maintaining a healthy weight while preserving lean muscle and improving overall health.
“This year, we are focused on revitalizing our coach and customer

Read more...